Literature DB >> 8961623

Immunodeficiency mutation databases--a new research tool.

C I Smith1, M Vihinen.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8961623     DOI： 10.1016/0167-5699(96)30063-7

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  7 in total

Review 1.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?

Authors:  S A Weston; M L Prasad; C G Mullighan; H Chapel; E M Benson
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Primary immunodeficiency diseases in Norway.

Authors:  A Stray-Pedersen; T G Abrahamsen; S S Frøland
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 4.  The Human Variome Project: ensuring the quality of DNA variant databases in inherited renal disease.

Authors:  Judy Savige; Raymond Dalgleish; Richard Gh Cotton; Johan T den Dunnen; Finlay Macrae; Sue Povey
Journal:  Pediatr Nephrol       Date:  2014-11-11       Impact factor: 3.714

5.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

Authors:  M Vihinen; O Brandau; L J Brandén; S P Kwan; I Lappalainen; T Lester; J G Noordzij; H D Ochs; J Ollila; S M Pienaar; P Riikonen; B K Saha; C I Smith
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

Review 6.  Cellular and molecular basis of immunodeficiencies: their consequences for the development and induction of the immune response.

Authors:  J Sterzl
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

Review 7.  From identification of the BTK kinase to effective management of leukemia.

Authors:  C I E Smith
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.